Posted inBiotechnology
Optical Tweezers Probe Whey-Chitosan Emulsion Stability
In a groundbreaking study that could revolutionize food science and biotechnology, researchers have employed optical tweezers to delve deeply into…
Posted inBiotechnology
Varroa destructor: Honey Bee Parasite and Management Strategies
Honey bees, scientifically known as Apis spp., are indispensable to global ecosystems and agriculture, serving as critical pollinators for a…
Posted inBiotechnology
Assessing the FAST Walk System for Enhancing Gait Recovery in Chronic Stroke Patients Through Neuromodulation
Stroke remains a formidable global health challenge, ranking as one of the top causes of long-term disability. Among its most…
Posted inBiotechnology
Pusan National University Introduces 3D-Printed Brain Vessels to Revolutionize Atherosclerosis Research
In a groundbreaking study, researchers led by Professor Byoung Soo Kim at Pusan National University have developed a revolutionary 3D-bioprinted…
Posted inBiotechnology
Unlocking Sour Taste: How SNAP25 Drives Flavor Signals and Sustains Sensory Cell Health
The human tongue is a marvel of sensory biology, equipped with taste buds that enable us to perceive a wide…
Posted inMedical Technology
Nighttime insulin patch pump maker Luna Diabetes raises $23.6M
The maker of a new category of small, wearable insulin patch pumps—designed to comfortably provide therapy to people with diabetes…
Posted inBiotechnology
FDA rejection derails PTC Therapeutics’ rare disease hopeful
PTC Therapeutics has long been trying to workshop its vatiquinone into a marketable treatment for Friedreich's ataxia (FA) after a…
Posted inMedical Technology
Medtronic expands board to chase M&A, efficiencies as activist investor takes stake
Medtronic has agreed to not only expand the size of its board of directors, but to also task it with…
Posted inBiotechnology
Viking hits stormy seas as phase 2 oral obesity data sink stock
Viking Therapeutics has reported phase 2 data on its oral obesity drug candidate, linking the peptide to weight loss of up…
Posted inBiotechnology
FDA pushes back PDUFA date for Regenxbio’s Hunter syndrome gene therapy
Delays from the FDA continue to pile up, with Maryland-based Regenxbio the latest to report the review of one of…